Navigation Links
BioNanomatrix to Introduce nanoAnalyzer® 1000 System
Date:10/27/2010

PHILADELPHIA, Oct. 27 /PRNewswire/ -- BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, will introduce next month the nanoAnalyzer 1000 System at the American Society of Human Genetics (ASHG) Annual Meeting from November 2-6, 2010 in Washington, D.C.

The nanoAnalyzer 1000 System is intended for advanced analyses of DNA and other macromolecules and consists of a disposable nanochannel silicon-based device, analytical instrumentation, software and reagents.  The system is currently being tested in collaboration with leading researchers in the genomics field.

"This event is the culmination of several years of effort to develop a complete system for state-of-the-art analyses of DNA and potentially other large molecules of biological interest," said Edward L. Erickson, BioNanomatrix's president and chief executive officer.  "We expect to make the nanoAnalyzer 1000 System available to early access customers following the New Year."

The company further announced that it is developing a wide range of applications for the nanoAnalyzer 1000 System, including:

  • Assessment of DNA sample quality for advanced sequencing and other genomic analysis methods;
  • Assessment of DNA damage induced by environmental factors such as ionizing radiation and pollutants;
  • Adjunctive methods for assisting researchers in genome assembly, assembly validation, finishing and scaffolding; and
  • Identification and analysis of structural variations in genomic DNA.

  • The nanoAnalyzer 1000 System on display at Booth #723 at ASHG, which is being held at the Walter E. Washington Convention Center in Washington, D.C.  Inquiries concerning the company and its products should be addressed to info@bionanomatrix.com.

    About BioNanomatrix

    BioNanomatrix, Inc., a privately held genomics company, is developing and commercializing game-changing, proprietary technologies for analysis of large biological molecules, such as nucleic acids that are extremely important in life science research, clinical diagnostic applications, and development of new therapeutics.  This technology is designed to reduce dramatically the time and complexity to analyze the genome and provide additional information, including structural variation data.  BioNanomatrix's products will provide users with the means to perform many single-molecule analyses on minute biological samples that are essentially impossible, impractical or too expensive with current technology.  For more information, visit: www.bionanomatrix.com.

    Note: NANOANALYZER is a registered trademark of BioNanomatrix, Inc. The names of other companies, other entities, products and/or services mentioned herein may be the trademarks of their respective owners. Media Contact:  Tiberend Strategic Advisors, Inc. (212) 827-0020 Farrell Denbyfdenby@tiberendstrategicadvisors.com orAndrew Mielach amielach@tiberendstrategicadvisors.com
    '/>"/>

    SOURCE BioNanomatrix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology news :

    1. Motorola Solutions Introduces Industrys Most Comprehensive Enterprise Device Management Platform
    2. Elsevier introduces Protein Viewer, bringing science to life
    3. Aware to Introduce Several New Software Products at the Biometrics Consortium Conference
    4. InQ Biosciences Introduces First Fully Integrated Cell Research System
    5. Orbel Introduces the Board Shielding Wizard
    6. Cermetek Introduces Medically Approved Modem Module
    7. Olympus introduces the VisiGlide, a single-use guidewire
    8. Advanced Analogic Technologies Introduces Lowest-Power Load Switch Available for Biometric Security Devices
    9. Reintroduced Chinese alligators now multiplying in the wild in China
    10. New blackberry introduced
    11. e-Smart Technologies to Introduce Next Generation I AM Smart Card Technology at Cartes 2008 in Paris
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
    (Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: ... announced that Richard P. Moberg has resigned, ... co-President and Chief Financial Officer and Treasurer of Aware ... to serve as a member of the Board of ... , Aware,s co-Chief Executive Officer and co-President, General Counsel ...
    (Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
    Breaking Biology News(10 mins):
    (Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
    (Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
    (Date:3/22/2017)... 22, 2017   VWR (NASDAQ: ... product and service solutions to laboratory and ... acquired EPL Archives, Inc., an international biorepository ... entire regulated product research, development and commercialization ... and ancillary services. EPL Archives is widely ...
    (Date:3/22/2017)... , ... March 21, 2017 , ... Benchworks ... Chief Executive Officer Forum on March 23-24 in San Diego. The event is ... and diagnostic industries. , Benchworks Vice President Christian Meyer will also participate in ...
    Breaking Biology Technology: